wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8B
Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8B
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes.
P2860
Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52679023-61891162-A154-4A1C-815B-C76CEBF71A8B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b419d82731998f470a05e394d048e1b81541b9d9
P2860
Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib.